Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.860 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,393,920
Open 1.850
Bid (Size) 1.860 (17)
Ask (Size) 1.880 (8)
Prev. Close 1.860
Today's Range 1.800 - 1.880
52wk Range 1.040 - 3.815
Shares Outstanding 403,828,955
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders
From Sarissa Capital Management LP
Via Business Wire
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
From Amarin Corporation plc
Via Globe NewsWire

Performance

YTD
+56.30%
+56.30%
1 Month
+56.30%
+56.30%
3 Month
+44.19%
+44.19%
6 Month
+39.85%
+39.85%
1 Year
-48.62%
-48.62%

More News

Read More
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via Globe NewsWire
Why Amarin Stock Tumbled This Week
Via The Motley Fool
Why Amarin Stock Was a Winner Today
Via The Motley Fool
3 Penny Stocks to Sell in January Before They Peter Out
Via InvestorPlace
Amarin Calls Activist Investor, Largest Shareholder Sarissa's Statement 'Inaccurate, Misleading'
Via Benzinga
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
From Sarissa Capital Management LP
Via Business Wire
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
From Amarin Corporation plc
Via Globe NewsWire
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
From Sarissa Capital Management LP
Via Business Wire
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via Globe NewsWire
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via Globe NewsWire
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via Globe NewsWire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
From Amarin Corporation plc
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.